Search
Jasper Therapeutics Inc
JSPRAdd to Watchlist
16.860USD
-405.420-96.01%
Close 11-06 16:00（ET）
560.93MMarket Cap
LossP/E TTM
Jasper Therapeutics Inc (JSPR) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Jasper Therapeutics Inc in the past month.
Buy
0 Strong Buy
3 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
8.750USD+1582.05%
JSPR Analyst Recommendation Trends
In the current month, JSPR has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. JSPR average Analyst price target in the last month is 8.750.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
1
1
1
1
1
1
3
3
2
3
3
4
4
5
1
1
2
3
4
3
3
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
5
7
8
8
8
8
Financial Forecasting
Based on analysts' estimates, JSPR EPS is projected to reach -0.100 in FY2026Q3, following reported EPS of -0.096 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.74
-0.49
-0.35
-0.10
-0.30
Actual
-0.32
-0.04
-0.10
--
--
Surprise
+57.50%
+91.59%
+72.69%
--
--
FAQs
What is Jasper Therapeutics Inc's price target?
Analysts forecast that Jasper Therapeutics Inc's price target is USD 10.50, with the highest forecast at USD 25.00 and the lowest forecast at USD 5.00.
How have Jasper Therapeutics IncJSPR's recent earnings per share performed?
The market expectation was USD -0.10, while Jasper Therapeutics IncJSPR's earnings per share (EPS) for the previous quarter was USD -0.04. EPS for the next quarter is expected at USD -0.10.
What is the analyst rating for Jasper Therapeutics Inc?
Based on the ratings of Jasper Therapeutics Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.